PANZYGA

This brand name is authorized in Austria, Canada, Ecuador, Estonia, Spain, Ireland, Lithuania, Malta, Netherlands, Poland, Romania, United Kingdom, United States

Active ingredients

The drug PANZYGA contains one active pharmaceutical ingredient (API):

1 Human normal immunoglobulin G UNII 66Y330CJHS - HUMAN IMMUNOGLOBULIN G

Human normal immunoglobulin contains mainly immunoglobulin G (IgG) with a broad spectrum of antibodies against infectious agents. Human normal immunoglobulin contains the IgG antibodies present in the normal population. It is usually prepared from pooled plasma from not fewer than 1000 donors. Read about Human normal immunoglobulin G

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PANZYGA Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J06BA02	Immunoglobulins, normal human, for intravascular adm.	J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BA Immunoglobulins, normal human
Discover more medicines within J06BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02456087
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 188-MBE-0421
Country: EE	Ravimiamet	Identifier(s): 1683604, 1683615, 1683626, 1683637, 1683648, 1683659, 1683660, 1683671, 1683682
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 81045
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 353796, 353801, 353805
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1076348, 1080159, 1080160, 1080161, 1080162, 1080163, 1080164, 1080165, 1080166
Country: MT	Medicines Authority	Identifier(s): MA1219/00501, MA1219/00502, MA1219/00503, MA1219/00504, MA1219/00505, MA1219/00506, MA1219/00507
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 132063, 80039, 80047, 80055, 80063, 80071, 94242
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100343719
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65358001, W65358002, W65358003, W65358004, W65358005, W65358006, W65358007, W65358008, W65358009
Country: US	FDA, National Drug Code	Identifier(s): 0069-1011, 0069-1109, 0069-1224, 0069-1312, 0069-1415, 0069-1558, 68982-820